Harris Williams Advises Knox Lane on its Strategic Investment in Fingerpaint

Harris Williams, a global investment bank specializing in M A advisory services, announces it advised Knox Lane, a leading middle market investment firm focused on the consumer and services sectors, on its strategic investment in Fingerpaint, a full-service health and wellness marketing agency with five offices across the U.S. The transaction was led by Paul Hepper of the Harris Williams Healthcare Life Sciences (HCLS) Group and Dan Linsalata of the firm’s Technology Group. Independent by design, with integrated talent across five offices in New York, Pennsylvania, Arizona, New Jersey and California, Fingerpaint is built on a foundation of empathy and at its core is committed to creating and executing meaningful brand experiences for healthcare providers, care partners and patients. In 2020, Fingerpaint acquired 1798, a market access and commercialization firm located in La Jolla, California, adding to its portfolio of services in support of biopharma customers. The agency also launched Photo 51, a gene therapy consultancy. Fingerpaint was named 2019 Agency of the Year by Med Ad News, and in 2018, it won the Heart Award from Med Ad News for its commitment to philanthropy and social causes. Additionally, it has been on Inc. Magazine's list of the 5,000 Fastest-Growing Companies for the past seven years.
（以上内容由医药魔方AI生成）